SOAT1 and autoimmune disease: As illustrated in a dot plot (Figure 3B), the top prioritised pathway is the JAK-STAT signalling, which aligns with current interests targeting this pathway in inflammatory and autoimmune diseases (40), particularly for treating inflammatory bowel disease (41).